Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

NYSEARCA:ELA - NYSE Arca - US29402E1029 - Common Stock - Currency: USD

5.79  -0.01 (-0.17%)

After market: 5.79 0 (0%)

Fundamental Rating

7

Overall ELA gets a fundamental rating of 7 out of 10. We evaluated ELA against 121 industry peers in the Specialty Retail industry. ELA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ELA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make ELA suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ELA was profitable.
In the past year ELA had a positive cash flow from operations.
ELA had positive earnings in each of the past 5 years.
Each year in the past 5 years ELA had a positive operating cash flow.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

ELA has a better Return On Assets (9.22%) than 81.97% of its industry peers.
The Return On Equity of ELA (13.32%) is better than 70.49% of its industry peers.
ELA's Return On Invested Capital of 10.31% is fine compared to the rest of the industry. ELA outperforms 72.95% of its industry peers.
ELA had an Average Return On Invested Capital over the past 3 years of 12.62%. This is in line with the industry average of 13.07%.
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROIC 10.31%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 3.89%, ELA is in the better half of the industry, outperforming 72.95% of the companies in the same industry.
In the last couple of years the Profit Margin of ELA has grown nicely.
The Operating Margin of ELA (4.73%) is better than 67.21% of its industry peers.
ELA's Operating Margin has improved in the last couple of years.
The Gross Margin of ELA (24.35%) is worse than 74.59% of its industry peers.
In the last couple of years the Gross Margin of ELA has grown nicely.
Industry RankSector Rank
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELA is creating some value.
The number of shares outstanding for ELA has been reduced compared to 1 year ago.
The number of shares outstanding for ELA has been reduced compared to 5 years ago.
Compared to 1 year ago, ELA has an improved debt to assets ratio.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.39 indicates that ELA is not in any danger for bankruptcy at the moment.
The Altman-Z score of ELA (7.39) is better than 97.54% of its industry peers.
ELA has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as ELA would need 3.28 years to pay back of all of its debts.
ELA has a better Debt to FCF ratio (3.28) than 72.95% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ELA is not too dependend on debt financing.
ELA has a Debt to Equity ratio of 0.18. This is in the better half of the industry: ELA outperforms 65.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Altman-Z 7.39
ROIC/WACC1.12
WACC9.22%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 4.51 indicates that ELA has no problem at all paying its short term obligations.
The Current ratio of ELA (4.51) is better than 98.36% of its industry peers.
ELA has a Quick Ratio of 2.31. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ELA (2.31) is better than 93.44% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 2.31
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.67% over the past year.
ELA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.12% yearly.
The Revenue has grown by 15.71% in the past year. This is quite good.
ELA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.07% yearly.
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%

3.2 Future

ELA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.39% yearly.
ELA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.74% yearly.
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.68 indicates a rather expensive valuation of ELA.
Based on the Price/Earnings ratio, ELA is valued a bit cheaper than the industry average as 67.21% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.98, ELA is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.97 indicates a correct valuation of ELA.
ELA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ELA is cheaper than 64.75% of the companies in the same industry.
ELA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 20.68
Fwd PE 14.97
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ELA.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.37
EV/EBITDA 13.47
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ELA's earnings are expected to grow with 24.39% in the coming years.
PEG (NY)0.71
PEG (5Y)1.03
EPS Next 2Y24.39%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ELA!.
Industry RankSector Rank
Dividend Yield N/A

ENVELA CORP

NYSEARCA:ELA (6/27/2025, 8:04:02 PM)

After market: 5.79 0 (0%)

5.79

-0.01 (-0.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/dmh
Earnings (Next)08-05 2025-08-05/amc
Inst Owners13.65%
Inst Owner Change5.35%
Ins Owners49.42%
Ins Owner Change0.2%
Market Cap150.54M
Analysts80
Price Target9.69 (67.36%)
Short Float %1.62%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.13%
Min EPS beat(2)18.81%
Max EPS beat(2)41.44%
EPS beat(4)4
Avg EPS beat(4)31.9%
Min EPS beat(4)18.81%
Max EPS beat(4)48.51%
EPS beat(8)5
Avg EPS beat(8)9.86%
EPS beat(12)8
Avg EPS beat(12)25.22%
EPS beat(16)12
Avg EPS beat(16)26.31%
Revenue beat(2)2
Avg Revenue beat(2)9.94%
Min Revenue beat(2)2.14%
Max Revenue beat(2)17.74%
Revenue beat(4)4
Avg Revenue beat(4)15.97%
Min Revenue beat(4)2.14%
Max Revenue beat(4)22.84%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)4.74%
Revenue beat(16)12
Avg Revenue beat(16)7.62%
PT rev (1m)18.75%
PT rev (3m)18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.68%
Valuation
Industry RankSector Rank
PE 20.68
Fwd PE 14.97
P/S 0.8
P/FCF 37.37
P/OCF 19.99
P/B 2.73
P/tB 3.16
EV/EBITDA 13.47
EPS(TTM)0.28
EY4.84%
EPS(NY)0.39
Fwd EY6.68%
FCF(TTM)0.15
FCFY2.68%
OCF(TTM)0.29
OCFY5%
SpS7.26
BVpS2.12
TBVpS1.83
PEG (NY)0.71
PEG (5Y)1.03
Profitability
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROCE 13.18%
ROIC 10.31%
ROICexc 14.95%
ROICexgc 17.82%
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
FCFM 2.13%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Debt/EBITDA 0.93
Cap/Depr 211.79%
Cap/Sales 1.86%
Interest Coverage 23.43
Cash Conversion 71.1%
Profit Quality 54.86%
Current Ratio 4.51
Quick Ratio 2.31
Altman-Z 7.39
F-Score7
WACC9.22%
ROIC/WACC1.12
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.46%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year58.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.44%
OCF growth 3Y53.73%
OCF growth 5YN/A